Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia

The discovery of proprotein convertase subtilisin-kexin type 9 (PCSK9), a serine protease which binds to the low-density lipoprotein (LDL) receptors and targets the receptors for lysosomal degradation, offered an additional route through which plasma LDL-cholesterol (LDL-C) levels can be controlled....

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, Constantine E., Muñoz Estrella, Alba, Sourlas, Andreas, Silverio, Delia, Hilario, Elizabeth, Montan, Peter D., Guzman, Eliscer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163360/
https://www.ncbi.nlm.nih.gov/pubmed/30011788
http://dx.doi.org/10.3390/diseases6030063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163360/
https://www.ncbi.nlm.nih.gov/pubmed/30011788
http://dx.doi.org/10.3390/diseases6030063

Ejemplares similares